Vascular Pharmacology, 1537-1891

Tidskrift

Fler filtreringsmöjligheter
  1. 2018
  2. B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice

    Sara Rattik, Polyxeni T. Mantani, Ingrid Yao Mattisson, Ljungcrantz, I., Sundius, L., Harry Björkbacka, Terrinoni, M., Lebens, M., Holmgren, J., Jan Nilsson, Maria Wigren & Nordin Fredrikson, G., 2018, I : Vascular Pharmacology. 111, s. 54-61

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. 2016
  4. Homocysteine regulates endothelin type B receptors in vascular smooth muscle cells

    Chen, Y., Zhang, H., Liu, E., Xu, C. B. & Zhang, Y., 2016 dec 1, I : Vascular Pharmacology. 87, s. 100-109 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. 2014
  6. Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression.

    Xu, C-B., Zheng, J., Zhang, W., Liu, E., Lars Edvinsson & Zhang, Y., 2014, I : Vascular Pharmacology. 60, 1, s. 42-48

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2008
  8. Effect of nitric oxide on responses of the human uterine arteries to vasopressin

    Kostrzewska, A., Modzelewska, B., Kleszczewski, T. & Satish Batra, 2008, I : Vascular Pharmacology. 48, 1, s. 9-13

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2007
  10. Potential effects of PKC or protease inhibitors on acute pancreatitis-induced tissue injury in rats.

    Shi, C., Zhao, X., Wang, X., Zhao, L. & Roland Andersson, 2007, I : Vascular Pharmacology. 46, 6, s. 406-411

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism.

    Lindholm, M. & Jan Nilsson, 2007, I : Vascular Pharmacology. 46, Jul 25, s. 91-96

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2006
  13. Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca(2+) influx and release.

    Cao, Y-X., Zhang, W., He, J-Y., He, L-C. & Xu, C-B., 2006, I : Vascular Pharmacology. 45, 3, s. 171-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2005
  15. Evaluation of nasal barrier dysfunction at acute- and late-phase reactions in a guinea pig model of allergic rhinitis

    Elovsson, S., Smailagic, A., Erjefalt, I., Zackrisson, C., Eriksson, C. & Wang, X., 2005, I : Vascular Pharmacology. 43, 4, s. 267-276

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2004
  17. Differential effects of rapamycin, cyclosporine A, and FK506 on human coronary artery smooth muscle cell proliferation and signalling

    Hafizi, S., Mordi, VN., Andersson, KM., Chester, AH. & Yacoub, MH., 2004, I : Vascular Pharmacology. 41, 4-5, s. 167-176

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. 1998
  19. Antimalarial drugs inhibit phospholipase A2 activation and induction of interleukin 1beta and tumor necrosis factor alpha in macrophages

    Bondeson, J. & Sundler, R., 1998, I : General Pharmacology. 30, 3, s. 357-66

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Föregående 1 2 Nästa